backKing & Spalding advised LBO France on the sale of Dutscher Group, a leading European distributor of consumables and equipment for R&D laboratories, to Vivo Capital, a global healthcare-focused investment firm.
The transaction represents the culmination of a six-year value creation journey since LBO France’s investment in 2020. During this period, Dutscher accelerated its growth through 13 strategic acquisitions across Europe, strengthened its logistics platform with the construction of three new distribution centers, expanded into adjacent markets, and surpassed €400 million in revenue.
The transaction also marks Vivo Capital’s first investment in Europe, highlighting the firm's ambition to further expand its international footprint in the healthcare sector. More information can be found here.
King & Spalding advised LBO France with a cross-border team from its Paris and London offices, comprising Thomas Philippe, Victor Dumesnil, Olivier Goldstein, Alexandre Chagneau, Alice Mony, Lucie Dubecq-Princeteau, Aurélie Chazottes, Elisabeth Ouart, Guillaume Chaboureau, Houda Idaroussi, Marcus Young, Tessa Cranfield, Zara Gasztowicz and Annie Fan.